SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-242400
Filing Date
2022-09-12
Accepted
2022-09-12 07:07:29
Documents
8
Period of Report
2022-09-12

Document Format Files

Seq Description Document Type Size
1 6-K d351583d6k.htm 6-K 11284
2 EX-99.1 d351583dex991.htm EX-99.1 11191
3 EX-99.2 d351583dex992.htm EX-99.2 35327
4 EX-99.3 d351583dex993.htm EX-99.3 35120
5 GRAPHIC g351583g0909193202133.jpg GRAPHIC 2601
6 GRAPHIC g351583g0909193202508.jpg GRAPHIC 1154
7 GRAPHIC g351583g0909193203071.jpg GRAPHIC 1085
8 GRAPHIC g351583g0909193514352.jpg GRAPHIC 2704
  Complete submission text file 0001193125-22-242400.txt   105097
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 221237362
SIC: 2834 Pharmaceutical Preparations